Home

StemCore Laboratories

StemCore Laboratories is a high-throughput genomics facility within the Ottawa Hospital Research Institute (OHRI), and is a core facility of the University of Ottawa. StemCore Laboratories is developing a world-class infrastructure for genomics, bioinformatics, and proteomics, and is capable of facilitating large-scale scientific research and biotechnology projects. Stemcore Laboratories seeks out projects that are challenging, cutting-edge, extend the boundaries of biological knowledge, and will positively impact the state of human health.

 

 News

 

 Upcoming 2013 Canadian Bioinformatics Workshops are quickly approaching!

New for 2013:
-     A 3-day Pathway and Network Analysis workshop to accommodate transcriptional regulation
-     Back-to-back workshops for better skill extension and application 
-     New workshops in RNA-seq Analysis and Flow Cytometry
 
The CBW is pleased to be offering the following advanced training opportunities in 2013 in Toronto:
·     Exploratory Analysis of Biological Data using R: May 23-24, 2013
·     Bioinformatics for Cancer Genomics: May 27-31, 2013
·     (NEW) Informatics for RNA-Seq Analysis: June 3-4, 2013
·     Informatics on High-Throughput Sequencing Data:  June 6-7, 2013
·     Pathway and Network Analysis of –omics Data: June 10-12, 2013
·     (NEW) Flow Cytometry Data Analysis using R: June 17-18, 2013
·     Microarray Data Analysis: June 24-25, 2013
·     Informatics and Statistics for Metabolomics: July 4-5, 2013
 
A link to the full program poster can be found at: http://bioinformatics.ca/workshops
 
 
APTAMERS and the state of the technology.

The Ontario Genomics Institute (OGI) and NeoVentures Biotechnology Inc.(www.neoventures.ca) are hosting a one hour web conference/webinar about APTAMERS and the state of the technology Friday, March 15 at 1:30 PM EST. NeoVentures has been the first company globally to commercialize aptamer based diagnostics.

With an aptamer-based diagnostic platform there is no need for the maintenance of recombinant cell lines, and antibody production schedules. Aptamers can be chemically synthesized at a commercial scale within a week enabling true on-demand inventory control.

The webinar will cover:

  • Introduction to aptamers
  • Strengths and weaknesses relative to antibodies
  • Aptamer identification
  • Considerations for aptamer based diagnostics
  • Intellectual property landscape
  • NeoVentures services

The presentation will be led by Dr. Greg Penner, President & CEO. The webinar will be appropriate for all levels of research investigators that are interested in learning how aptamer based diagnostic applications can compete directly with antibodies in commercial products.

Please be sure to REGISTER and provide your name, title, institution and valid email address so that we can send you an email with webinar details and instructions.

  

Past Events

 

Ottawa Illumina Seminar 2013: The Age of Personalized Medicine

Tuesday, February 19, 2013 , 8:45 AM - 3:00 PM (registration opens at 7:30 AM)
University of Ottawa - Health Sciences Building , Roger Guindon Hall, Amphitheatre A (RGN Room 2005)

See what NGS can do for your research.

Space is limited, please register at: eventregistration.illumina.com/d/wcq4c1

 

The IRC 2010 OHRI Workshop on Next Generation Sequencing and ChIP-Seq Data Analysis tutorials are now available online.

Bioinformatics Hands-on Training Session,  Pathway and Network Analysis

 

 

Back Row (from left to right) : William Read (Project Manager), Jon Allan (Trainee), Caroline Vergette (Nest Generation Sequencing), Paul Oleynik (Flow Cytometry) 
Front row (from left to right) : Pearl Campbell (Director), Kathy Sheikheleslamy (Laboratory Manager, microarray), Atieh Jalali-Pakdaman (DNA Sequencing)

 

 

Funding for StemCore Laboratories has been provided by: 

Government of Ontario, Ottawa Hospital Research Institute, University of Ottawa,

Genome Canada, The Ontario Genomics Institute, Canada Foundation for Innovation, Stem Cell Network, Stantive Solutions